A RANDOMIZED, ACTIVE-CONTROLLED RATER-BLINDED 2-YEAR STUDY OF PALIPERIDONE PALMITATE VERSUS INVESTIGATORS' CHOICE OF ORAL ANTIPSYCHOTIC MONOTHERAPY IN PATIENTS WITH SCHIZOPHRENIA (PROSIPAL)

dc.contributor.author	Hargarter, L.
dc.contributor.author	Schreiner, A.
dc.contributor.author	Aadamsoo, K.
dc.contributor.author	Altamura, A. C.
dc.contributor.author	Franco, M.
dc.contributor.author	Goorwood, P.
dc.contributor.author	Neznanov, N. G.
dc.contributor.author	Schronen, J.
dc.contributor.author	Zink, M.
dc.contributor.author	Cherubin, P.
dc.contributor.author	Lahaye, M.
dc.contributor.author	Ucok, A.
dc.date.accessioned	2021-03-04T17:53:51Z
dc.date.available	2021-03-04T17:53:51Z
dc.identifier.citation	Schreiner A., Aadamsoo K., Altamura A. C. , Franco M., Goorwood P., Neznanov N. G. , Schronen J., Ucok A., Zink M., Cherubin P., et al., "A RANDOMIZED, ACTIVE-CONTROLLED RATER-BLINDED 2-YEAR STUDY OF PALIPERIDONE PALMITATE VERSUS INVESTIGATORS' CHOICE OF ORAL ANTIPSYCHOTIC MONOTHERAPY IN PATIENTS WITH SCHIZOPHRENIA (PROSIPAL)", EUROPEAN PSYCHIATRY, cilt.29, 2014
dc.identifier.issn	0924-9338
dc.identifier.other	av_87d4f074-b4e3-47d0-b7b5-af33ee8f7730
dc.identifier.other	vv_1032021
dc.identifier.uri	http://hdl.handle.net/20.500.12627/92223
dc.language.iso	eng
dc.subject	Sağlık Bilimleri
dc.subject	Psikiyatri
dc.subject	Klinik Tıp (MED)
dc.title	A RANDOMIZED, ACTIVE-CONTROLLED RATER-BLINDED 2-YEAR STUDY OF PALIPERIDONE PALMITATE VERSUS INVESTIGATORS' CHOICE OF ORAL ANTIPSYCHOTIC MONOTHERAPY IN PATIENTS WITH SCHIZOPHRENIA (PROSIPAL)
dc.type	Makale
dc.relation.journal	EUROPEAN PSYCHIATRY
dc.contributor.department	Johnson & Johnson , ,
dc.identifier.volume	29
dc.contributor.firstauthorID	212976

Bu öğenin dosyaları:

Dosyalar	Boyut	Biçim	Göster
Bu öğe ile ilişkili dosya yok.